From: Adenosine as cardioprotective in off-pump coronary artery bypass grafting
Adenosine group (n = 24) | Control group (n = 25) | p value | ||
---|---|---|---|---|
Age (year) | 55 ± 12.3 | 53 ± 11.2 | 0.55 | |
Sex | ♂ | 20 (83.3%) | 19 (76%) | 0.52 |
♀ | 4 (16.7%) | 6 (24%) | ||
BMI (kg/m2) | 27.8 ± 4.1 | 28.5 ± 5.04 | 0.59 | |
Number of grafts | Single graft | 13 (54.17%) | 12 (48%) | 0.9 |
Two grafts | 7 (29.6%) | 8 (32%) | ||
Three grafts | 4 (16.7%) | 5 (20%) | ||
Incidence of | Pre-op MI | 18 (75%) | 17 (68%) | 0.58 |
Diabetes | 9 (37.5%) | 11 (44%) | 0.64 | |
Hypertension | 15 (62.5%) | 16 (64%) | 0.91 | |
Preoperative EF (%) | 59 ± 9.5 | 55 ± 11.1 | 0.18 |